Critical Care

official impact factor 4.60

Open Access Highly Access Research

Anti-Xa activity after subcutaneous administration of dalteparin in ICU patients with and without subcutaneous oedema: a pilot study

Mirjam K Rommers*, Netty Van Der Lely, Toine CG Egberts and Patricia MLA van den Bemt

Critical Care 2006, 10:R93 doi:10.1186/cc4952


See related commentary by Crowthe and Lim, http://ccforum.com/10/4/150

No comments have yet been made on this article.

Post a comment